Breaking News
December 17, 2018 - CTF along with NTAP and Sage announce first-ever open data portal for neurofibromatosis
December 17, 2018 - Intimacy: The Elusive Fountain of Youth?
December 17, 2018 - Will saliva translate to a real diagnostic tool?
December 17, 2018 - DFG establishes nine new Research Units and one new Clinical Research Unit
December 17, 2018 - Assisted living’s breakneck growth leaves patient safety behind
December 17, 2018 - America’s teens report dramatic increase in their use of vaping devices in just one year
December 17, 2018 - Enlarged heart linked to a higher risk of dementia
December 17, 2018 - Prostate cancer detection using MRI now first-line investigation tool
December 17, 2018 - Loughborough academics part of new project investigating effectiveness of personalized breast cancer screening
December 17, 2018 - Adolescents who use cognitive reappraisal had better metabolic measures, shows study
December 17, 2018 - Probiotics may offer therapeutic benefits for biopolar patients
December 17, 2018 - Stealth BioTherapeutics Granted Fast Track Designation for Elamipretide for the Treatment of Dry Age-Related Macular Degeneration with Geographic Atrophy
December 17, 2018 - Studies reveal role of red meat in gut bacteria, heart disease development
December 17, 2018 - Eisai enters into agreement with Eurofarma for its anti-obesity agent lorcaserin
December 17, 2018 - Researchers use brain connectome to reassess neuroimaging findings of Alzheimer’s disease
December 17, 2018 - “Miracle” baby survives Ebola in Congo and rapid a new Ebola detection device
December 17, 2018 - Mechanisms behind neonatal diabetes uncovered
December 17, 2018 - AHF urges the WHO to expedite approval process for vaccine effective against Ebola
December 17, 2018 - Study finds misuse of benzodiazepines to be highest among young adults
December 17, 2018 - TGen receives PayPal grant to underwrite costs of genetic tests for children with rare disorders
December 17, 2018 - New research highlights why HIV-infected patients suffer higher rates of cancer
December 17, 2018 - Antibiotic-resistant bacteria could soon be targeted with Alzheimer’s drug
December 17, 2018 - Rutgers scientists take an important step in making diseased hearts heal themselves
December 17, 2018 - Tailored Feedback at CRC Screen Improves Lifestyle Behaviors
December 17, 2018 - Loss of two genes drives a deadly form of colorectal cancer, reveals a potential treatment
December 17, 2018 - How the Mediterranean Diet Can Help Women’s Hearts
December 17, 2018 - Sustained connections associated with symptoms of autism
December 17, 2018 - Concussion rates among young football players were higher than previously reported
December 17, 2018 - Cresco Labs granted approval to operate marijuana dispensary in Ohio
December 17, 2018 - Study provides insight into health risks facing new mothers
December 17, 2018 - AMSBIO expands Wnt signaling pathway product range to aid research
December 16, 2018 - Surgical treatment unnecessary for many prostate cancer patients
December 16, 2018 - Excess weight responsible for cancers globally finds report
December 16, 2018 - Regular sex associated with greater enjoyment of life in seniors
December 16, 2018 - Social stigma contributes to poor mental health in the autistic community
December 16, 2018 - Multidisciplinary team successfully performs complex surgery on patient suffering from enlarged skull
December 16, 2018 - Experts analyze data that can guide antidepressant discontinuation
December 16, 2018 - Menlo Therapeutics’ Successful Phase 2 Clinical Trial of Serlopitant Demonstrates Reduction of Pruritus Associated with Psoriasis
December 16, 2018 - Siblings of children with autism or ADHD are at elevated risk for both disorders
December 16, 2018 - New project aims to understand why and how metabolic disorders develop in patients
December 16, 2018 - Diets containing GM maize have no harmful effects on health or metabolism of rats
December 16, 2018 - Are doctors and teachers confusing immaturity and attention deficit?
December 16, 2018 - Hearing loss linked with increased risk for premature death
December 16, 2018 - Chromatrap buffer reagents for lysing cells offer many benefits
December 16, 2018 - Young Breast Cancer Patients Face Higher Risk for Osteoporosis
December 16, 2018 - 3-D printing offers helping hand to people with arthritis
December 16, 2018 - Community Health Choice helps manage complex and chronic care conditions
December 16, 2018 - Regular trips out could dramatically reduce depression in older age
December 16, 2018 - CWRU to use VivaLNK’s Vital Scout device for stress study in student athletes
December 16, 2018 - ‘Easy Way Out’? Stigma May Keep Many From Weight Loss Surgery
December 16, 2018 - Gout drug may protect against chronic kidney disease
December 16, 2018 - Talking about memories enhances the wellbeing of older and younger people
December 16, 2018 - Occupational exposure to pesticides increases risk for cardiovascular disease among Latinos
December 16, 2018 - A biomarker in the brain’s circulation system may be Alzheimer’s earliest warning
December 16, 2018 - Magnesium may play important role in optimizing vitamin D levels, study shows
December 16, 2018 - The effect of probiotics on intestinal flora of premature babies
December 16, 2018 - Parents spend more time talking with kids about mechanics of using mobile devices
December 16, 2018 - Biohaven Announces Positive Results from Ongoing Rimegepant Long-Term Safety Study
December 16, 2018 - Arterial stiffness may predict dementia risk
December 16, 2018 - Study explores link between work stress and increased cancer risk
December 16, 2018 - Sex work criminalization linked to incidences of violence finds study
December 16, 2018 - Johns Hopkins researchers discover swarming behavior in fish-dwelling parasite
December 16, 2018 - Schistosomiasis prevention and treatment could help control HIV
December 16, 2018 - Early postpartum opioids linked with persistent usage
December 16, 2018 - Johns Hopkins researchers identify molecular causes of necrotizing enterocolitis in preemies
December 16, 2018 - Advanced illumination expands capabilities of light-sheet microscopy
December 16, 2018 - Alzheimer’s could possibly be spread via contaminated neurosurgery
December 16, 2018 - Unraveling the complexity of cancer biology can prompt new avenues for drug development
December 16, 2018 - Inflammatory Bowel Disease, Prostate Cancer Linked
December 16, 2018 - Cannabis youth prevention strategy should target mental wellbeing
December 15, 2018 - Recent developments and challenges in hMAT inhibitors
December 15, 2018 - Sewage bacteria found lurking in Hudson River sediments
December 15, 2018 - CDC selects UMass Amherst biostatistician model that helps predict influenza outbreaks
December 15, 2018 - Researchers reveal brain mechanism that drives itch-evoked scratching behavior
December 15, 2018 - New computer model helps predict course of the disease in prostate cancer patients
December 15, 2018 - Obesity to Blame for Almost 1 in 25 Cancers Worldwide
December 15, 2018 - How the brain tells you to scratch that itch
December 15, 2018 - New findings could help develop new immunotherapies against cancer
December 15, 2018 - World’s largest AI-powered medical research network launched by OWKIN
December 15, 2018 - Young people suffering chronic pain battle isolation and stigma as they struggle to forge their identities
Oxehealth secures European medical device accreditation for vital signs measurement software

Oxehealth secures European medical device accreditation for vital signs measurement software

image_pdfDownload PDFimage_print

Oxford University spin-off secures European medical device certification for software enabling a digital video camera to remotely detect pulse and breathing rate, with the potential to transform care for elderly and vulnerable people in rooms where staff cannot always be present

The British Standards Institute (BSI) has accredited Oxehealth’s vital signs measurement software as a Class IIa medical device in Europe.

This is the first time that software enabling a digital video camera sensor to remotely measure vital signs has been approved as a medical device.

No global medical device regulator, including the US Food and Drug Administration, has previously approved a device of this nature.

To detect pulse rate, the device works in the same way as the familiar pulse oximeter, which detects the slight changes in skin color caused by the blood being pumped around the body.

However, unlike a pulse oximeter, which must be attached to a patient’s skin, it can be used to monitor pulse rate remotely. The device also detects the movements of the body caused by breathing to count breathing rate.

The Oxehealth vital signs measurement software will now be marketed alongside the company’s existing suite of contact-free activity tracking tools, which are already being used by NHS trusts and care homes to assist staff who need to monitor patients at risk of falls, self-harm or other injuries.  

Chief executive Hugh Lloyd-Jukes said:

I am thrilled by the European medical device accreditation, which confirms that our technology can take spot measurements of pulse rate and breathing rate that are as accurate and safe as a device that you clip on the skin.

Pulse oximeters are used in GP practices and hospitals every day. The difference is that we measure pulse rate and breathing rate entirely contact free, anywhere in the patient’s room.

This will be hugely beneficial to public and private sector organizations that care for elderly and vulnerable people, whose staff cannot be present in every room or do not wish to interrupt the rest of the people they are looking after.”

The European medical device accreditation is the culmination of six years’ work by Oxehealth, a spinout from Oxford University’s Institute of Biomedical Engineering and Oxford University Hospitals NHS Foundation Trust.  From the start, the company worked closely with clinicians.

The first clinical studies were completed at the John Radcliffe Hospital in Oxford and tests were later conducted at the Broadmoor Psychiatric Hospital and Coventry and Warwickshire Partnership NHS Trust.

To secure the accreditation, the company had to complete a clinical pivotal study to prove the efficacy of its product, and to build a medical device Quality Management System covering its software development and business processes. Both were assessed by The British Standards Institute, acting as a Notified Body on behalf of the MHRA.

The Oxehealth vital signs measurement software will now be launched as part of the company’s Digital Care Assistant solution, which uses an optical sensor to pay attention to patients when clinicians cannot be with them. The DCA software alerts staff to risky situations, such as a patient getting out of bed, leaving a room, or moving into a risky area, so staff can intervene quickly.

The system also generates reports that give teams objective data on activity. These are invaluable in shift handover meetings and for understanding patient behavior.

Lloyd-Jukes added:

Clinicians have been using the Digital Care Assistant to help them to identify risky activities and to understand patient activity better.

The addition of the medical device solution will enable organizations to take pulse and breathing rate observations to inform treatment decisions. It is a world first that has the potential to help staff transform care in settings where they cannot, or do not want to, enter a room.

Looking after the elderly and vulnerable can be extremely challenging. Yet, in contrast to their peers in intensive care, the medical staff working in mental health, nursing homes and custodial settings have never had access to frequent, accurate vital sign measurements.

Now they do, and we are thrilled to be bringing them a 21st Century tool that will help them improve the care of some of society’s most frail patients.”

Source:

https://www.oxehealth.com/

Tagged with:

About author

Related Articles